My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$HD {{ '2015-11-17T12:17:02+0000' | timeago}} • Announcement

Home improvement retailer $HD said net earnings grew 13% to $1.7Bil or $1.35 per share in 3Q15 from $1.5Bil or $1.15 per diluted share in 3Q14, helped by growth in transactions from both DIY and Pro customers. Sales grew 6.4% to $21.8Bil.

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

User RC xNair {{ '2016-10-26T18:36:03+0000' | timeago}}

Chipotle stock is crashing like a falling knife after it's earnings report last evening; down about 10% already today! Was Bill Ackman wrong in buying about 10% stake in $CMG couple of months ago? Or is this market reacting to disappointing earnings? And can they really get customers to trust them again after food-safety crisis?

$BMY {{ '2016-10-27T14:56:24+0000' | timeago}} • Webcast

In the US, $BMY said it is expecting to get a decision on its Opdivo application for head and neck cancer in a couple of weeks. Based on the current assumptions for 2017, the company is expecting Opdivo sales to grow globally and also in the US.

$EQT {{ '2016-10-27T14:55:48+0000' | timeago}} • Webcast

$EQT said David Porges intends to retire as CEO in early 2017 and transition at that time to the role of Executive Chairman. Steve Schlotterbeck is expected to be the next CEO.

$UPS {{ '2016-10-27T14:55:03+0000' | timeago}} • Webcast

$UPS stated that B2B (Business to Business) growth was 2% and B2C (Business to Customer) growth was in double digits in 3Q16. There was growth in B2B despite the softness in industrial production. The company expects this growth to continue through peak season.

$UHS {{ '2016-10-27T14:53:36+0000' | timeago}} • Webcast

$UHS expects FY16 adjusted net income to be in the range of $7.16-7.43 per diluted share, up from the prior year range of $7.12-7.58. The increase in net income is based on the operating trends and financial results experienced in 2016.

$EQT {{ '2016-10-27T14:50:41+0000' | timeago}} • Webcast

$EQT currently forecasts approx. $750MM of operating cash flow for 2016. This includes about $150MM of distributions from $EQGP.